Search research articles
Contact Us
Filters
Showing results (81-90 of 393) with videos related to
Page
of 40
Sort By:
British Journal of Anaesthesia
|
December 1, 1988
Comparison of propofol and thiamylal for induction and maintenance of anaesthesia for outpatient surgery
I H Sampson, H Plosker, M Cohen, et al.
Oncoimmunology
|
May 8, 2015
miR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment
Regina Lin, John H Sampson, Qi-Jing Li, et al.
Neuro-Oncology
|
May 13, 2015
Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma
Gordana Vlahovic, Peter E Fecci, David Reardon, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|
August 31, 2001
Inflammatory myositis: a rare differential diagnosis of a neck lump
A Tsikoudas, R J England, J D Fenwick, et al.
Pharmacology & Therapeutics
|
December 18, 2018
Effective effectors: How T cells access and infiltrate the central nervous system
Kendra L Congdon, Luis A Sanchez-Perez, John H Sampson
Clinical & Developmental Immunology
|
March 9, 2012
Toxin-based targeted therapy for malignant brain tumors
Vidyalakshmi Chandramohan, John H Sampson, Ira Pastan, et al.
Neurosurgery
|
March 30, 2004
Microvascular decompression for glossopharyngeal neuralgia: long-term effectiveness and complication avoidance
John H Sampson, Peter M Grossi, Katsuyuki Asaoka, et al.
Neurosurgery Clinics of North America
|
December 1, 2009
The role of tregs in glioma-mediated immunosuppression: potential target for intervention
William Humphries, Jun Wei, John H Sampson, et al.
The Veterinary Record
|
March 5, 1977
Competitive trail and endurance riding in the UK
P K Hall-Patch, R G Orton, J H Sampson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2020
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Mustafa Khasraw, David A Reardon, Michael Weller, et al.
Page
of 40
Search research articles
Search
Showing results (81-90 of 393) with videos related to
Sort By:
Page
of 40
British Journal of Anaesthesia
|
December 1, 1988
Comparison of propofol and thiamylal for induction and maintenance of anaesthesia for outpatient surgery
I H Sampson, H Plosker, M Cohen, et al.
Oncoimmunology
|
May 8, 2015
miR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment
Regina Lin, John H Sampson, Qi-Jing Li, et al.
Neuro-Oncology
|
May 13, 2015
Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma
Gordana Vlahovic, Peter E Fecci, David Reardon, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|
August 31, 2001
Inflammatory myositis: a rare differential diagnosis of a neck lump
A Tsikoudas, R J England, J D Fenwick, et al.
Pharmacology & Therapeutics
|
December 18, 2018
Effective effectors: How T cells access and infiltrate the central nervous system
Kendra L Congdon, Luis A Sanchez-Perez, John H Sampson
Clinical & Developmental Immunology
|
March 9, 2012
Toxin-based targeted therapy for malignant brain tumors
Vidyalakshmi Chandramohan, John H Sampson, Ira Pastan, et al.
Neurosurgery
|
March 30, 2004
Microvascular decompression for glossopharyngeal neuralgia: long-term effectiveness and complication avoidance
John H Sampson, Peter M Grossi, Katsuyuki Asaoka, et al.
Neurosurgery Clinics of North America
|
December 1, 2009
The role of tregs in glioma-mediated immunosuppression: potential target for intervention
William Humphries, Jun Wei, John H Sampson, et al.
The Veterinary Record
|
March 5, 1977
Competitive trail and endurance riding in the UK
P K Hall-Patch, R G Orton, J H Sampson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2020
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Mustafa Khasraw, David A Reardon, Michael Weller, et al.
Page
of 40